Shares of Oncobiologics Inc (NASDAQ:ONS) saw an uptick in trading volume on Wednesday . 1,167,879 shares were traded during trading, an increase of 973% from the previous session’s volume of 108,826 shares.The stock last traded at $1.42 and had previously closed at $1.29.

The company has a quick ratio of 0.03, a current ratio of 0.03 and a debt-to-equity ratio of -0.01.

An institutional investor recently raised its position in Oncobiologics stock. Sabby Management LLC increased its stake in Oncobiologics Inc (NASDAQ:ONS) by 5.7% during the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 2,365,763 shares of the company’s stock after purchasing an additional 127,293 shares during the quarter. Sabby Management LLC owned approximately 9.59% of Oncobiologics worth $2,371,000 at the end of the most recent quarter. 18.52% of the stock is currently owned by institutional investors.

COPYRIGHT VIOLATION WARNING: This piece was first published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this piece on another site, it was copied illegally and reposted in violation of international copyright law. The correct version of this piece can be viewed at

Oncobiologics Company Profile

Oncobiologics, Inc is a clinical-stage biopharmaceutical company. The Company is focused on identifying, developing, manufacturing and commercializing biosimilar therapeutics. It is focused on monoclonal antibodies (mAbs) in the disease areas of immunology and oncology. The Company offers BioSymphony Platform.

Receive News & Stock Ratings for Oncobiologics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oncobiologics Inc and related stocks with our FREE daily email newsletter.